Evidence map›Paper›PMID 39583292›Full record

ArticleAmerican journal of ophthalmology case reports2024

Clinico-pathologic correlation in ocular sarcoidosis.

Arthi Rao, Jodi Hwang, Joyce Wen, Sarah Edminster, Maria Sibug-Saber, Narsing Rao, Brian C Toy

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arthi RaoRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Jodi HwangRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Joyce WenRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Sarah EdminsterRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Maria Sibug-SaberRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Narsing RaoRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Brian C ToyRoski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Funding

Investigating the Development, Persistence, and Progression of Uveitis and Ocular Inflammation in the United StatesK23EY032985 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TOY, BRIAN · 2021 to 2025
$820k
NEI NIH HHS K23 EY032985
6 · The paper itself

Abstract

Purpose: This case describes the unique course and management of a patient with progressive, refractory multi-system sarcoidosis that initially presented with ocular and dermatologic findings. Observations: A 47-year-old male presented with acute anterior uveitis and was found to have simultaneous inflammation of his skin at a tattoo site. Diagnosis of ocular sarcoidosis was confirmed through skin biopsy. Treatment with prednisone and adalimumab was initiated. Despite systemic immunosuppression and control of systemic inflammation, the patient had refractory ocular disease and developed bilateral disc edema and peripapillary choroidal neovascular membranes with subretinal fluid, so oral methotrexate and as-needed intravitreal bevacizumab injections were added. However, the patient manifested hepatic and worsening pulmonary involvement, prompting discontinuation of both methotrexate and adalimumab. Biopsy of the liver later confirmed hepatic sarcoidosis over drug-induced liver injury. Out of precaution for methotrexate-associated hepatic toxicity, mycophenolate mofetil was initiated instead, which then led to resolution of the subretinal fluid and disease quiescence. Conclusions and Importance: This case offers insight into the varying presentation and recalcitrant course of sarcoidosis. It documents a clinicopathologic case with unique initial presentation with biopsies of multiple organs, escalation of therapy with several immunomodulatory agents, and multidisciplinary collaboration to achieve ocular and systemic quiescence.

Indexed as

Choroidal neovascularizationOcular sarcoidTattooUveitis

Identifiers

PMID39583292
PMCPMC11584688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.